'Market Realizing That Endp Is The Real Beneficiary Of Opioid Settlement As Reported Fundamentals Have Improved Since Stock Was At $18 A Year Ago. Low Or No Cash Payout.Good Fcf, Bal Sheet, And Strong Pipeline. If Reporting Is True ENDP Can Be $10 On MNK' -Citron Research
Benzinga Newsdesk